Shanghai Shen Lian Biomedical CorporationSSE: 688098

Report for Q1 2026

Apr 29, 2026 · Issued by Shanghai Shen Lian Biomedical Corporation via Shanghai Stock Exchange

Filed with SSE · Apr 29, 2026

On 6ix: 6ix.com/news/report-for-q1-2026-547

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shanghai Shen Lian Biomedical Corporation on 6ix

Earlier from Shanghai Shen Lian Biomedical

Announcement on Voluntary Disclosure of the Company Re-certified as High-tech EnterpriseApr 22
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Mar 13
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Notice on Convening the 1st Extraordinary General Meeting in 2026Feb 25
Announcement on Equity Change of Shareholder with Over 5% Shares Reaching 1% Scale, Completion of Shareholding Reduction Plan and Results of Shares SoldFeb 10

Later from Shanghai Shen Lian Biomedical

Announcement on Resolutions of the 2025 Annual General MeetingMay 21
Announcement on Resolutions of the 1st Holders' Meeting for 2026 Employee Stock Ownership PlanMay 28
Announcement on the Completion of Non-Trade Transfer under the 2026 Employee Stock Ownership PlanJun 9
Announcement on Voluntary Disclosure of Approval Numbers for Veterinary Drug ProductsJun 24
Announcement on Voluntary Disclosure of Obtaining the Approval Document for a Veterinary Drug ProductJul 3

All Shanghai Shen Lian Biomedical news releases

Follow Shanghai Shen Lian Biomedical into a list and get an email when it puts out news.

Follow Shanghai Shen Lian Biomedical